LT2630954T - Levodopos įvedimas į plaučius - Google Patents

Levodopos įvedimas į plaučius

Info

Publication number: LT2630954T
Authority: LT; Lithuania
Prior art keywords: levodopa; pulmonary delivery; pulmonary; delivery
Prior art date: 2002-03-20

Application number

LTEP13161929.8T

Other languages

English (en)

Inventor

Blair Jackson

David J. Bennett

Raymond T. Bartas

Dwaine F. Emerich

Original Assignee

Civitas Therapeutics, Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-03-20

Filing date

2003-03-19

Publication date

2017-01-25

2003-03-19 Application filed by Civitas Therapeutics, Inc. filed Critical Civitas Therapeutics, Inc.

2017-01-25 Publication of LT2630954T publication Critical patent/LT2630954T/lt

Links

WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 title 1
WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 title 1
229960004502 levodopa Drugs 0.000 title 1
230000002685 pulmonary effect Effects 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Pulmonology (AREA)
Otolaryngology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Inorganic Chemistry (AREA)
Emergency Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Psychology (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

LTEP13161929.8T 2002-03-20 2003-03-19 Levodopos įvedimas į plaučius LT2630954T (lt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US36647102P	2002-03-20	2002-03-20

Publications (1)

Publication Number	Publication Date
LT2630954T true LT2630954T (lt)	2017-01-25

Family

ID=28454804

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LTEP13161929.8T LT2630954T (lt)	2002-03-20	2003-03-19	Levodopos įvedimas į plaučius

Country Status (13)

Country	Link
US (7)	US7879358B2 (lt)
EP (3)	EP2630954B1 (lt)
JP (1)	JP4384503B2 (lt)
AU (1)	AU2003218307B8 (lt)
CA (1)	CA2478980C (lt)
CY (1)	CY1118517T1 (lt)
DK (2)	DK2630954T3 (lt)
ES (3)	ES2389156T3 (lt)
HU (1)	HUE031167T2 (lt)
LT (1)	LT2630954T (lt)
PT (3)	PT1531798E (lt)
SI (1)	SI2630954T1 (lt)
WO (1)	WO2003079992A2 (lt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2003218307B8 (en)	2002-03-20	2006-08-31	Alkermes, Inc.	Pulmonary delivery for levodopa
GB0321607D0 (en)	2003-09-15	2003-10-15	Vectura Ltd	Manufacture of pharmaceutical compositions
BRPI0608844A2 (pt) *	2005-03-09	2010-02-02	Ono Pharmaceutical Co	partìcula e preparação que contém a partìcula
ECSP077628A (es) *	2007-05-03	2008-12-30	Smithkline Beechman Corp	Nueva composición farmacéutica
GB2454480A (en) *	2007-11-07	2009-05-13	Vectura Group Plc	Pulmonary inhalation of levodopa containing compositions in the treatment of Parkinsons disease and other central nervous system disorders
ES2625260T5 (es)	2009-03-26	2020-07-29	Pulmatrix Operating Co Inc	Formulaciones de polvo seco y métodos para el tratamiento de enfermedades pulmonares
WO2012030645A1 (en)	2010-08-30	2012-03-08	Pulmatrix, Inc.	Respirably dry powder comprising calcium lactate, sodium chloride and leucine
CN103200938B (zh)	2010-08-30	2018-07-31	普马特里克斯营业公司	干燥粉末配方及用于治疗肺部疾病的方法
BR112013007304B1 (pt)	2010-09-29	2021-12-14	Pulmatrix, Inc.	Pós secos de cátion de metal monovalente para inalação
PT3470057T (pt)	2010-09-29	2021-12-03	Pulmatrix Operating Co Inc	Pós secos catiónicos compreendendo sais de magnésio
CN107596518B (zh)	2012-02-29	2021-04-23	普马特里克斯营业公司	可吸入干粉剂
KR20210075224A (ko)	2012-10-22	2021-06-22	키비타스 테라퓨틱스, 인코포레이티드.	파킨슨병의 빠른 경감을 위한 레보도파 제형
SG11201503128TA (en) *	2012-10-22	2015-05-28	Civitas Therapeutics Inc	Reducing inter-patient variability of levodopa plasma concentrations
BR112015010601B1 (pt) *	2012-11-09	2022-07-19	Civitas Therapeutics, Inc.	Composição farmacêutica e uso da composição
US8545878B1 (en) *	2012-11-09	2013-10-01	Civitas Therapeutics, Inc.	Capsules containing high doses of levodopa for pulmonary use
US20140150787A1 (en)	2012-12-04	2014-06-05	Civitas Therapeutics, Inc.	Devices and methods for puncturing a capsule to release a powdered medicament therefrom
AU2014248455B2 (en)	2013-04-01	2018-12-06	Pulmatrix Operating Company, Inc.	Tiotropium dry powders
US20160317542A1 (en)	2013-12-09	2016-11-03	Respira Therapeutics, Inc.	Pde5 inhibitor powder formulations and methods relating thereto
TWI589308B (zh) *	2014-03-25	2017-07-01	林信湧	一種用於治療帕金森氏症之吸入式醫藥組成物及其備製方法
EP3134077A4 (en) *	2014-04-21	2017-12-20	Civitas Therapeutics, Inc.	Rapid relief of motor fluctuations in parkinson's disease
MA40910A (fr)	2014-11-07	2017-09-12	Civitas Therapeutics Inc	Poudres de rapamycine pour administration pulmonaire
CN113197851A (zh)	2015-05-06	2021-08-03	辛纳吉勒公司	包含药物粒子的药用悬浮液、用于其配给的装置、以及其使用方法
WO2017004501A1 (en)	2015-07-02	2017-01-05	Civitas Therapeutics, Inc.	Triptan powders for pulmonary delivery
WO2018138581A1 (en)	2017-01-30	2018-08-02	Globalmed, Inc.	Heated respiratory hose assembly
US11517548B2 (en) *	2018-07-19	2022-12-06	Impel Pharmaceuticals Inc.	Respiratory tract delivery of levodopa and DOPA decarboxylase inhibitor for treatment of Parkinson's Disease
JP2019108379A (ja) *	2019-03-05	2019-07-04	サイヴィタスセラピューティックス，インコーポレイテッド	パーキンソン病の運動症状変動の迅速な緩和
IT202000030437A1 (it) *	2020-12-10	2022-06-10	Zambon Spa	Metodo per la realizzazione di una polvere inalabile comprendente voriconazolo
US12005185B2 (en) *	2021-12-17	2024-06-11	Belhaven BioPharma Inc.	Medical counter measures including dry powder formulations and associated methods
CN121443315A (zh)	2023-07-05	2026-01-30	上海汉都医药科技有限公司	药物组合物、含其的制剂、套装及其制备方法和应用

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3689643A (en) *	1971-01-27	1972-09-05	Abbott Lab	Combination of l-dopa, 2-imino-5-phenyl-4-oxazolidinone and an aluminum or alkaline earth metal salt or base used to treat parkinson{40 s disease
US4069819A (en)	1973-04-13	1978-01-24	Societa Farmaceutici S.P.A.	Inhalation device
US4511258A (en)	1983-03-25	1985-04-16	Koflo Corporation	Static material mixing apparatus
JPS6122019A (ja)	1984-07-06	1986-01-30	Tomio Konno	吸入細胞活性薬品とその使用方法
GB8501015D0 (en) *	1985-01-16	1985-02-20	Riker Laboratories Inc	Drug
JPS63500175A (ja) *	1985-05-22	1988-01-21	リポソ−ム　テクノロジ−，インコ−ポレイテツド	リポソ−ム吸入法および吸入システム
IT1228459B (it)	1989-02-23	1991-06-19	Phidea S R L	Inalatore con svuotamento regolare e completo della capsula.
US6048857A (en) *	1989-10-17	2000-04-11	Ellinwood, Jr.; Everett H.	Dosing method of administering medicaments via inhalation administration
US5118494A (en) *	1990-03-23	1992-06-02	Minnesota Mining And Manufacturing Company	Use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
CA2081474A1 (en)	1990-05-08	1991-11-09	Manzer Durrani	Direct spray-dried drug/lipid powder composition
US5166202A (en) *	1990-09-19	1992-11-24	Trustees Of The University Of Pennsylvania	Method for the treatment of panic disorder
JPH0697804A (ja) *	1991-01-08	1994-04-08	Nec Corp	論理回路
GB9101592D0 (en)	1991-01-24	1991-03-06	Glaxo Group Ltd	Compositions
PT533268E (pt) *	1991-09-18	2002-02-28	Glaxo Group Ltd	Derivados de benzanilida como antagonistas de 5-ht1d
US5457100A (en) *	1991-12-02	1995-10-10	Daniel; David G.	Method for treatment of recurrent paroxysmal neuropsychiatric
US5756071A (en) *	1992-06-03	1998-05-26	Arrowdean Limited	Method for nasally administering aerosols of therapeutic agents to enhance penetration of the blood brain barrier
US5284133A (en) *	1992-07-23	1994-02-08	Armstrong Pharmaceuticals, Inc.	Inhalation device with a dose-timer, an actuator mechanism, and patient compliance monitoring means
AU5171293A (en) *	1992-10-14	1994-05-09	Regents Of The University Of Colorado, The	Ion-pairing of drugs for improved efficacy and delivery
US5354885A (en)	1992-12-24	1994-10-11	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Process for preparing ethyl ester of L-DOPA
ATE416755T1 (de)	1994-03-07	2008-12-15	Nektar Therapeutics	Verfahren und zusammensetzung für die pulmonale darreichung von insulin
CA2152684A1 (en)	1994-07-01	1996-01-02	Richard Anthony Henry	Aerosol delivery of midazolam
US6019968A (en) *	1995-04-14	2000-02-01	Inhale Therapeutic Systems, Inc.	Dispersible antibody compositions and methods for their preparation and use
US6165463A (en) *	1997-10-16	2000-12-26	Inhale Therapeutic Systems, Inc.	Dispersible antibody compositions and methods for their preparation and use
US5654007A (en) *	1995-06-07	1997-08-05	Inhale Therapeutic Systems	Methods and system for processing dispersible fine powders
GB9606677D0 (en) *	1996-03-29	1996-06-05	Glaxo Wellcome Inc	Process and device
US5875776A (en) *	1996-04-09	1999-03-02	Vivorx Pharmaceuticals, Inc.	Dry powder inhaler
US5874064A (en) *	1996-05-24	1999-02-23	Massachusetts Institute Of Technology	Aerodynamically light particles for pulmonary drug delivery
US5855913A (en) *	1997-01-16	1999-01-05	Massachusetts Instite Of Technology	Particles incorporating surfactants for pulmonary drug delivery
US5985309A (en) *	1996-05-24	1999-11-16	Massachusetts Institute Of Technology	Preparation of particles for inhalation
US6254854B1 (en)	1996-05-24	2001-07-03	The Penn Research Foundation	Porous particles for deep lung delivery
US6103270A (en) *	1996-06-07	2000-08-15	Inhale Therapeutic Systems	Methods and system for processing dispersible fine powders
CA2277801C (en)	1997-01-16	2002-10-15	Massachusetts Institute Of Technology	Preparation of particles for inhalation
US6193954B1 (en) *	1997-03-21	2001-02-27	Abbott Laboratories	Formulations for pulmonary delivery of dopamine agonists
US5958902A (en)	1997-04-16	1999-09-28	Wisconsin Alumni Research Foundation	Method and composition for treating sleep apnea
NZ516083A (en)	1999-05-27	2003-08-29	Acusphere Inc	Porous drug matrices and methods of manufacture thereof
US6858199B1 (en)	2000-06-09	2005-02-22	Advanced Inhalation Research, Inc.	High efficient delivery of a large therapeutic mass aerosol
US6461631B1 (en) *	1999-11-16	2002-10-08	Atrix Laboratories, Inc.	Biodegradable polymer composition
US6514482B1 (en)	2000-09-19	2003-02-04	Advanced Inhalation Research, Inc.	Pulmonary delivery in treating disorders of the central nervous system
US6613308B2 (en) *	2000-09-19	2003-09-02	Advanced Inhalation Research, Inc.	Pulmonary delivery in treating disorders of the central nervous system
AU2003218307B8 (en) *	2002-03-20	2006-08-31	Alkermes, Inc.	Pulmonary delivery for levodopa
US10156302B1 (en)	2016-02-09	2018-12-18	Blox, Llc	Mechanical electrical plumbing rack device

2003
- 2003-03-19 AU AU2003218307A patent/AU2003218307B8/en not_active Expired
- 2003-03-19 PT PT03714302T patent/PT1531798E/pt unknown
- 2003-03-19 SI SI200332506T patent/SI2630954T1/sl unknown
- 2003-03-19 DK DK13161929.8T patent/DK2630954T3/en active
- 2003-03-19 JP JP2003577824A patent/JP4384503B2/ja not_active Expired - Lifetime
- 2003-03-19 US US10/392,342 patent/US7879358B2/en not_active Ceased
- 2003-03-19 ES ES03714302T patent/ES2389156T3/es not_active Expired - Lifetime
- 2003-03-19 HU HUE13161929A patent/HUE031167T2/hu unknown
- 2003-03-19 EP EP13161929.8A patent/EP2630954B1/en not_active Expired - Lifetime
- 2003-03-19 CA CA002478980A patent/CA2478980C/en not_active Expired - Lifetime
- 2003-03-19 LT LTEP13161929.8T patent/LT2630954T/lt unknown
- 2003-03-19 PT PT121702377T patent/PT2494962E/pt unknown
- 2003-03-19 PT PT131619298T patent/PT2630954T/pt unknown
- 2003-03-19 EP EP12170237.7A patent/EP2494962B1/en not_active Expired - Lifetime
- 2003-03-19 EP EP03714302A patent/EP1531798B1/en not_active Expired - Lifetime
- 2003-03-19 ES ES12170237.7T patent/ES2487816T3/es not_active Expired - Lifetime
- 2003-03-19 DK DK03714302.1T patent/DK1531798T3/da active
- 2003-03-19 ES ES13161929.8T patent/ES2609482T3/es not_active Expired - Lifetime
- 2003-03-19 WO PCT/US2003/008659 patent/WO2003079992A2/en not_active Ceased
2010
- 2010-12-20 US US12/972,824 patent/US8404276B2/en not_active Expired - Fee Related
2011
- 2011-10-17 US US13/274,787 patent/USRE43711E1/en active Active
2013
- 2013-02-21 US US13/773,054 patent/US8586093B2/en not_active Expired - Fee Related
- 2013-10-17 US US14/055,959 patent/US9155699B2/en not_active Expired - Fee Related
2015
- 2015-09-10 US US14/849,950 patent/US20160058727A1/en not_active Abandoned
2016
- 2016-12-30 CY CY20161101363T patent/CY1118517T1/el unknown
2017
- 2017-04-06 US US15/480,956 patent/US20180055800A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US20160058727A1 (en)	2016-03-03
CA2478980A1 (en)	2003-10-02
EP1531798A4 (en)	2010-11-03
EP1531798A2 (en)	2005-05-25
AU2003218307B2 (en)	2006-07-27
US20140105983A1 (en)	2014-04-17
CY1118517T1 (el)	2017-07-12
ES2487816T3 (es)	2014-08-25
US9155699B2 (en)	2015-10-13
EP1531798B1 (en)	2012-06-06
HUE031167T2 (hu)	2017-07-28
JP4384503B2 (ja)	2009-12-16
US20040018989A1 (en)	2004-01-29
AU2003218307B8 (en)	2006-08-31
US20130164349A1 (en)	2013-06-27
ES2389156T3 (es)	2012-10-23
EP2494962A2 (en)	2012-09-05
DK1531798T3 (da)	2012-08-13
US20110151008A1 (en)	2011-06-23
WO2003079992A2 (en)	2003-10-02
PT2494962E (pt)	2014-08-27
CA2478980C (en)	2008-07-15
US20180055800A1 (en)	2018-03-01
USRE43711E1 (en)	2012-10-02
JP2006507218A (ja)	2006-03-02
PT2630954T (pt)	2017-01-05
US7879358B2 (en)	2011-02-01
PT1531798E (pt)	2012-09-10
DK2630954T3 (en)	2017-01-23
US8404276B2 (en)	2013-03-26
EP2630954B1 (en)	2016-10-05
ES2609482T3 (es)	2017-04-20
AU2003218307A1 (en)	2003-10-08
EP2494962B1 (en)	2014-05-14
SI2630954T1 (sl)	2017-02-28
EP2630954A1 (en)	2013-08-28
US8586093B2 (en)	2013-11-19
EP2494962A3 (en)	2013-01-16
WO2003079992A3 (en)	2005-03-31

Publication	Publication Date	Title
EP1531798A4 (en)	2010-11-03	PULMONARY LEVY OF LEVODOPA
EP1560569A4 (en)	2006-03-22	GASTRORETENTIVE LEVODOPA DELIVERY FORM
AU2003293632A8 (en)	2004-05-13	Phenethanolamine derivatives
AU154760S (en)	2004-03-02	Inhaler
AU2003296660A8 (en)	2004-07-09	Copolyamides
EP1483895A4 (en)	2007-12-12	MANUAL PRINTER-SCANNER
PL373240A1 (en)	2005-08-22	Polyisobutenamines
GB0214031D0 (en)	2002-07-31	Skate
GB0225750D0 (en)	2002-12-11	Wiffs away
DE60326941D1 (en)	2009-05-14	Rs
AU153471S (en)	2003-10-27	Inhaler
GB0215028D0 (en)	2002-08-07	Microarchitecture description
AU152924S (en)	2003-08-25	Inhaler
PL377054A1 (pl)	2006-01-23	Poliamidy
AU153470S (en)	2003-10-27	Inhaler
GB0202275D0 (en)	2002-03-20	Peptide
EP1584819A4 (en)	2006-08-23	COMPRESSOR
AU153472S (en)	2003-10-27	Inhaler
AU152923S (en)	2003-08-25	Inhaler
GB0210746D0 (en)	2002-06-19	Peptide
GB2385795B (en)	2005-05-18	Putt conceder
AU2003303145A8 (en)	2004-07-22	Formulations for pulmonary delivery
AU152926S (en)	2003-08-25	Inhaler
AU152925S (en)	2003-08-25	Inhaler
GB0215011D0 (en)	2002-08-07	Easy squeezy